$8.44
▲ +0.5% Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients
Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?
Overview
52-week range
$5.15
$9.32
79% of range
Avg surprise (last 3)
-13.0%
Avg reaction (last 2)
+1.9%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.23 | $-0.22 | -4.5% | -9.5% | +2.6% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.26 | $-0.21 | -23.8% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $-0.21 | $-0.19 | -10.5% | — | +1.2% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for EPRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.